UTAH MEDICAL PRODUCTS INC (UTMD) Stock Fundamental Analysis
USA - NASDAQ:UTMD - US9174881089 - Common Stock
57.08 USD
+0.06 (+0.11%)
We assign a fundamental rating of 6 out of 10 to UTMD. UTMD was compared to 189 industry peers in the Health Care Equipment & Supplies industry. UTMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. UTMD is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year UTMD was profitable.
In the past year UTMD had a positive cash flow from operations.
In the past 5 years UTMD has always been profitable.
UTMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 10.39%, UTMD belongs to the best of the industry, outperforming 93.12% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.68%, UTMD belongs to the top of the industry, outperforming 86.24% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.80%, UTMD belongs to the top of the industry, outperforming 87.83% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for UTMD is above the industry average of 9.01%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.39% | ||
| ROE | 10.68% | ||
| ROIC | 8.8% |
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
1.3 Margins
UTMD has a better Profit Margin (32.33%) than 96.30% of its industry peers.
UTMD's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 32.51%, UTMD belongs to the top of the industry, outperforming 98.94% of the companies in the same industry.
In the last couple of years the Operating Margin of UTMD has remained more or less at the same level.
UTMD has a Gross Margin (57.33%) which is in line with its industry peers.
In the last couple of years the Gross Margin of UTMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.51% | ||
| PM (TTM) | 32.33% | ||
| GM | 57.33% |
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UTMD is creating some value.
The number of shares outstanding for UTMD has been reduced compared to 1 year ago.
Compared to 5 years ago, UTMD has less shares outstanding
There is no outstanding debt for UTMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 36.65 indicates that UTMD is not in any danger for bankruptcy at the moment.
UTMD has a better Altman-Z score (36.65) than 96.83% of its industry peers.
UTMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 36.65 |
ROIC/WACC1.02
WACC8.63%
2.3 Liquidity
UTMD has a Current Ratio of 41.87. This indicates that UTMD is financially healthy and has no problem in meeting its short term obligations.
UTMD's Current ratio of 41.87 is amongst the best of the industry. UTMD outperforms 100.00% of its industry peers.
UTMD has a Quick Ratio of 38.22. This indicates that UTMD is financially healthy and has no problem in meeting its short term obligations.
UTMD has a better Quick ratio (38.22) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 41.87 | ||
| Quick Ratio | 38.22 |
3. Growth
3.1 Past
The earnings per share for UTMD have decreased strongly by -13.65% in the last year.
The Earnings Per Share has been growing slightly by 0.16% on average over the past years.
UTMD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.65%.
UTMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.70% yearly.
EPS 1Y (TTM)-13.65%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-3.95%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-4.3%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.26, which indicates a correct valuation of UTMD.
Based on the Price/Earnings ratio, UTMD is valued cheaply inside the industry as 86.24% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of UTMD to the average of the S&P500 Index (26.76), we can say UTMD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.26 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTMD is valued cheaper than 96.30% of the companies in the same industry.
94.71% of the companies in the same industry are more expensive than UTMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.28 | ||
| EV/EBITDA | 6.5 |
4.3 Compensation for Growth
The excellent profitability rating of UTMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)98.31
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.08%, UTMD has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.79, UTMD pays a better dividend. On top of this UTMD pays more dividend than 96.30% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, UTMD has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.08% |
5.2 History
The dividend of UTMD has a limited annual growth rate of 1.95%.
UTMD has paid a dividend for at least 10 years, which is a reliable track record.
UTMD has decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.95%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
32.72% of the earnings are spent on dividend by UTMD. This is a low number and sustainable payout ratio.
UTMD's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.72%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:UTMD (10/30/2025, 4:10:10 PM)
57.08
+0.06 (+0.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.57%
Inst Owner Change-0.75%
Ins Owners7.13%
Ins Owner Change-0.27%
Market Cap183.23M
Revenue(TTM)38.83M
Net Income(TTM)12.55M
Analysts0
Price TargetN/A
Short Float %3.82%
Short Ratio12.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.08% |
Yearly Dividend1.22
Dividend Growth(5Y)1.95%
DP32.72%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.26 | ||
| Fwd PE | N/A | ||
| P/S | 4.72 | ||
| P/FCF | 13.28 | ||
| P/OCF | 12.97 | ||
| P/B | 1.56 | ||
| P/tB | 1.81 | ||
| EV/EBITDA | 6.5 |
EPS(TTM)3.74
EY6.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.3
FCFY7.53%
OCF(TTM)4.4
OCFY7.71%
SpS12.1
BVpS36.61
TBVpS31.58
PEG (NY)N/A
PEG (5Y)98.31
Graham Number55.51
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.39% | ||
| ROE | 10.68% | ||
| ROCE | 10.65% | ||
| ROIC | 8.8% | ||
| ROICexc | 28.7% | ||
| ROICexgc | 51.67% | ||
| OM | 32.51% | ||
| PM (TTM) | 32.33% | ||
| GM | 57.33% | ||
| FCFM | 35.54% |
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
ROICexc(3y)38.7%
ROICexc(5y)33.39%
ROICexgc(3y)78.49%
ROICexgc(5y)75.65%
ROCE(3y)14.9%
ROCE(5y)14.86%
ROICexgc growth 3Y-5.7%
ROICexgc growth 5Y-2.21%
ROICexc growth 3Y5.77%
ROICexc growth 5Y9.65%
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
F-Score6
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 11.49% | ||
| Cap/Sales | 0.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.04% | ||
| Profit Quality | 109.9% | ||
| Current Ratio | 41.87 | ||
| Quick Ratio | 38.22 | ||
| Altman-Z | 36.65 |
F-Score6
WACC8.63%
ROIC/WACC1.02
Cap/Depr(3y)10.06%
Cap/Depr(5y)9.94%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.32%
Profit Quality(3y)119.58%
Profit Quality(5y)135.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.65%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-3.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-4.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.15%
EBIT growth 3Y-5.93%
EBIT growth 5Y-2.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.35%
FCF growth 3Y-10.92%
FCF growth 5YN/A
OCF growth 1Y-38.83%
OCF growth 3Y-11.23%
OCF growth 5Y-2.76%
UTAH MEDICAL PRODUCTS INC / UTMD FAQ
What is the ChartMill fundamental rating of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to UTMD.
What is the valuation status for UTMD stock?
ChartMill assigns a valuation rating of 5 / 10 to UTAH MEDICAL PRODUCTS INC (UTMD). This can be considered as Fairly Valued.
Can you provide the profitability details for UTAH MEDICAL PRODUCTS INC?
UTAH MEDICAL PRODUCTS INC (UTMD) has a profitability rating of 8 / 10.
What is the valuation of UTAH MEDICAL PRODUCTS INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for UTAH MEDICAL PRODUCTS INC (UTMD) is 15.26 and the Price/Book (PB) ratio is 1.56.